Top Stories
The deal gives Takeda's discovery teams direct access to Boltz's newest biomolecular foundation models, including BoltzMol-1 and BoltzProt-1.
The NFX-led financing round gives Portal runway through 2028 as it expands beyond drug screening into AI data generation and continues working on a DARPA-backed cell therapy manufacturing platform.
The Neuralink competitor is testing whether its fully implanted wireless BCI can preserve communication for people losing the ability to speak.
A fresh raise worth $17 million will help advance the biotech's preclinical programmes and expand its pharma collaborations.
The multi-year licensing deal will use the Stanford University spinout's lab-in-the-loop AI platform to identify novel candidates.
Conference News
Company to Showcase Integration of AI, Digital Batch Records, and Intelligent Robotics to Accelerate Pharmaceutical ManufacturingAGOURA HILLS, Calif., June 18, 2026 (GLOBE NEWSWIRE) -- Oncotelic Thera...
CHICAGO – The American Society of Anesthesiologists (ASA) today announced Medtronic, a global leader in healthcare technology, has reaffirmed its commitment to ASA’s Corporate Supporter Program, conti...
Growing body of evidence supports AlloSure® as a clinical endpoint for risk assessment, treatment response, and long-term graft outcomesData across kidney, heart, lung, and multi-organ transplantation...
Data, including seven oral presentations, highlight the clinical utility of Prospera™ across multiple organsAUSTIN, Texas--(BUSINESS WIRE)--Natera, Inc. (NASDAQ: NTRA), a global leader in cell-free DN...
YS Technology will launch its LumiSleep real-time brainwave-regulating sleep device at the World Artificial Intelligence Conference in Shanghai, Pandaily reports.The wearable headband uses seven dry e...
